EPR Properties vs Sabra Health Care REIT
EPR and SBRA side by side, both in miscellaneous investing. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How EPR and SBRA compare
EPR Properties and Sabra Health Care REIT are about the same size, with market caps of $4.6B and $5.2B.
On earnings, EPR Properties is cheaper: it trades at 16.9× trailing earnings, against 73.0× for Sabra Health Care REIT.
Sabra Health Care REIT grew revenue faster over the last twelve months (23.4% versus 7.3% for EPR Properties).
EPR Properties keeps more of each dollar of sales as profit, with a net margin of 38.8% compared with 7.8% at Sabra Health Care REIT.
Both pay dividends: EPR Properties yields 5.6% and Sabra Health Care REIT 7.3%.
EPR Properties scores higher on the StockData Score (11 against 6 for Sabra Health Care REIT), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | EPR | SBRA |
|---|---|---|
| Size and price | ||
| Market cap | $4.6B | $5.2B |
| Share price | $60.15 | $20.44 |
| Change, 1 year | 18.1% | 8.3% |
| Change, 5 years | 22.2% | 43.7% |
| Beta (5Y) | 0.72 | 0.46 |
| Employees | 54 | 58 |
| StockData Score | ||
| Total score | 11 (better) | 6 |
| Valuation score | 3 (better) | 0 |
| Growth score | 3 (better) | 1 |
| Performance score | 2 | 2 |
| Health score | 0 | 0 |
| Dividend score | 3 | 3 |
| Valuation | ||
| P/E | 16.9× (better) | 73.0× |
| P/S | 6.0× | 5.7× (better) |
| P/B | – | 1.8× |
| EV/EBITDA | 7.1× (better) | 12.7× |
| PEG | 0.98 | – |
| FCF yield | −4.7% | – |
| Fair value | $73.05 | $12.97 |
| Margin of safety | 17.7% (better) | −57.6% |
| Growth | ||
| Revenue growth (TTM) | 7.3% | 23.4% (better) |
| Revenue growth, 5Y average | 11.6% (better) | 5.3% |
| Net income growth (TTM) | 48.7% (better) | −59.2% |
| EPS growth (TTM) | 55.0% (better) | −61.1% |
| EPS growth, 5Y average | – | −0.91% |
| Profitability | ||
| Operating margin | 59.0% | – |
| Net margin | 38.8% (better) | 7.8% |
| FCF margin | −28.4% | – |
| Return on equity | – | 2.5% |
| Financial health | ||
| Interest coverage | 3.1× | – |
| Altman Z-score | 1.08 | 1.38 (better) |
| Piotroski F-score | 6 | 6 |
| Dividends and buybacks | ||
| Dividend yield | 5.6% | 7.3% (better) |
| Payout ratio | 101% | 423% |
| Years of dividend growth | 4 (better) | 0 |
| Dividend growth, 5Y average | 18.4% (better) | −2.3% |
| Buyback yield | 0.27% | – |
| Shareholder yield | 5.8% | 7.3% (better) |
| Ownership | ||
| Held by institutions | 82.8% | 102% |
| Held by insiders | 2.4% | 1.9% |
| Insider net buying, 12 months | −$5.3M | −$4.7M (better) |
| Short interest, % of float | 11.3% | 7.1% |
Go deeper
- EPR stock overview
- EPR income statement
- EPR valuation and score
- SBRA stock overview
- SBRA income statement
- SBRA valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.